BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35220510)

  • 1. Comprehensive complication index as a prognostic factor in minimally invasive esophagectomy for esophageal squamous cell carcinoma.
    Kudo T; Oshikiri T; Goto H; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Esophagus; 2022 Jul; 19(3):410-416. PubMed ID: 35220510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of minimally invasive total mesoesophageal excision and minimally invasive esophagectomy on failure patterns of locally advanced esophageal squamous cell carcinoma: a matched cohort study with long-term follow-up.
    Lin JH; Xu SJ; Chen C; You CX; Chen RQ; Zhang ZF; Kang MQ; Chen SC
    Surg Endosc; 2023 Oct; 37(10):7698-7708. PubMed ID: 37563344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Lymph Node Ratio on Survival Outcome in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
    Kitamura Y; Oshikiri T; Takiguchi G; Urakawa N; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2021 Aug; 28(8):4519-4528. PubMed ID: 33393049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel prognostic score of postoperative complications after transthoracic minimally invasive esophagectomy for esophageal cancer: a retrospective cohort study of 90 consecutive patients.
    Saito T; Tanaka K; Ebihara Y; Kurashima Y; Murakami S; Shichinohe T; Hirano S
    Esophagus; 2019 Apr; 16(2):155-161. PubMed ID: 30178429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer.
    Dolan JP; Kaur T; Diggs BS; Luna RA; Schipper PH; Tieu BH; Sheppard BC; Hunter JG
    Surg Endosc; 2013 Nov; 27(11):4094-103. PubMed ID: 23846365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
    Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
    BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term outcomes of thoracoscopic esophagectomy in the prone position for esophageal squamous cell carcinoma in patients with obstructive ventilatory disorder: a propensity score-matched study.
    Goto H; Oshikiri T; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Surg Endosc; 2022 Dec; 36(12):8834-8842. PubMed ID: 35546208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram for prognosis of patients with esophageal squamous cell cancer after minimally invasive esophagectomy established based on non-textbook outcome.
    Xu SJ; Lin LQ; Chen TY; You CX; Chen C; Chen RQ; Chen SC
    Surg Endosc; 2022 Nov; 36(11):8326-8339. PubMed ID: 35556169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and Nutritional Status Influences Outcomes of Minimally Invasive Esophagectomy.
    Xu SJ; Wang PL; Chen C; You CX; Chen RQ; Wu WW; Chen SC
    World J Surg; 2023 Apr; 47(4):1003-1017. PubMed ID: 36633646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy.
    Kato T; Oshikiri T; Goto H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Suzuki S; Kakeji Y
    J Surg Oncol; 2021 Dec; 124(7):1022-1030. PubMed ID: 34460103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer.
    Li KK; Wang YJ; Liu XH; Tan QY; Jiang YG; Guo W
    Surg Endosc; 2017 Sep; 31(9):3475-3482. PubMed ID: 27924395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy.
    Qi W; Zixiang W; Tianwei Z; Shuai F; Sai Z; Gang S; Ming W
    J Surg Oncol; 2018 Apr; 117(5):957-969. PubMed ID: 29878389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy.
    Koterazawa Y; Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2024 Apr; 31(4):2482-2489. PubMed ID: 38151622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Preoperative Platelet to Lymphocyte Ratio Is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment.
    Sasahara M; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Fujiwara M; Nakayama G; Kodera Y
    Dig Surg; 2023; 40(1-2):48-57. PubMed ID: 36893749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the short-term clinical outcome between open and minimally invasive esophagectomy by comprehensive complication index.
    Ma G; Cao H; Wei R; Qu X; Wang L; Zhu L; Du J; Wang Y
    J Cancer Res Ther; 2018; 14(4):789-794. PubMed ID: 29970654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.